Status: Recruiting
Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
This prospective, multi center cohort trial aims to evaluate the efficacy and safety of hysteropexy using Splentis via the vaginal route in primary uterine prolapse
Participants needed: 140
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: PromedonUpdated: Nov 22, 2024Locations: 7
Eligibility criteria
non-fertile women [+3]
Fertile women [+6]